chlordiazepoxide has been researched along with Anochlesia in 8 studies
Chlordiazepoxide: An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
chlordiazepoxide : A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Catalepsy was measured by recording the time the animal remained with its forepaws placed over a rod 6 cm above the bench." | 1.29 | NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists. ( Awere, S; Blackman, A; Leander, JD; Moore, NA, 1993) |
| "Pretreatment with flurazepam (3 mg/kg s." | 1.27 | Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. ( Greentree, SG; Pertwee, RG, 1988) |
| "Catalepsy was tested by the standard bar test 30 min after intraperitoneal treatment of HAL." | 1.27 | Potentiation of haloperidol-induced catalepsy by beta-adrenoceptor antagonists in mice. ( Hara, C; Ogawa, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, JK | 1 |
| Hotten, TM | 1 |
| Pullar, IA | 1 |
| Type, NC | 1 |
| Kikumoto, R | 1 |
| Tobe, A | 1 |
| Fukami, H | 1 |
| Egawa, M | 1 |
| FUJIMORI, H | 1 |
| COBB, DP | 1 |
| Moore, NA | 1 |
| Blackman, A | 1 |
| Awere, S | 1 |
| Leander, JD | 1 |
| Pertwee, RG | 2 |
| Wickens, AP | 1 |
| Greentree, SG | 1 |
| Hara, C | 1 |
| Ogawa, N | 1 |
| Boissier, JR | 1 |
| Simon, P | 1 |
| Villeneuve, A | 1 |
| Larousse, C | 1 |
8 other studies available for chlordiazepoxide and Anochlesia
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of a series of 4-piperazinylpyrazolo[3,4-b]- and -[4,3-b][1,5]benzodiazepines as potential anxiolytics.
Topics: Animals; Anti-Anxiety Agents; Azepines; Behavior, Animal; Catalepsy; Chemical Phenomena; Chemistry; | 1989 |
Synthesis and antianxiety activity of (omega-piperazinylalkoxy)indan derivatives.
Topics: Animals; Anti-Anxiety Agents; Body Temperature Regulation; Catalepsy; Humans; Indans; Indenes; Indic | 1983 |
CENTRAL NERVOUS SYSTEM DEPRESSANT ACTIVITY OF MA1337, 3-(3-(4-M-CHLOROPHENYL-1-PIPERAZYL)PROPYL)-2,4(1H,3H)QUINAZOLINEDIONE HYDROCHLORIDE.
Topics: Amphetamine; Amphetamines; Behavior, Animal; Body Temperature; Catalepsy; Cats; Central Nervous Syst | 1965 |
NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
Topics: Animals; Benzamides; Benzazepines; Catalepsy; Chlordiazepoxide; Dizocilpine Maleate; Dopamine D2 Rec | 1993 |
Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids.
Topics: Animals; Behavior, Animal; Cannabinoids; Catalepsy; Chlordiazepoxide; Dronabinol; Drug Interactions; | 1991 |
Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide.
Topics: Animals; Catalepsy; Chlordiazepoxide; Dronabinol; Drug Synergism; Flurazepam; Injections, Subcutaneo | 1988 |
Potentiation of haloperidol-induced catalepsy by beta-adrenoceptor antagonists in mice.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Catalepsy; Chlordiazepoxide; Dose-Response Relations | 1986 |
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous Sy | 1968 |